Stel Vianda S, Kramer Anneke, Zoccali Carmine, Jager Kitty J
ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
J Nephrol. 2009 Jan-Feb;22(1):1-12.
This paper provides a summary of the 2006 European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry report.
Data on renal replacement therapy (RRT) were available from 50 national and regional registries in 28 countries in Europe and bordering the Mediterranean Sea. Data sets with individual patient data were received from 35 registries, whereas 17 registries contributed data in aggregated form. For both types of registries we presented incidence, prevalence and transplant rates. Survival analysis and the calculation of expected remaining lifetimes were solely based on individual patient records.
In 2006, among all registries reporting to the ERA-EDTA Registry, the overall annual incidence rate of RRT was 118 per million population (pmp), and the prevalence was 630 pmp. Incidence rates varied from 213 pmp in Germany to 18 pmp in Ukraine. The overall incidence rate of RRT for end-stage renal disease (ESRD) started to decrease from 2004. The highest prevalence of RRT for ESRD was reported by Cantabria, Spain (1,234 pmp) and the lowest by Ukraine (73 pmp). Overall transplant rates were highest in Spain (61 pmp), whereas the highest transplant rates with living donor kidneys were reported from Iceland (26 pmp). The unadjusted 1-, 2- and 5-year survival of patients on RRT was 82.3 (95% confidence interval [95% CI], 82.0-82.5), 70.9 (95% CI, 70.7-71.2) and 47.5 (95% CI, 47.3-47.6) for the cohort 1997-2001, respectively.
本文提供了2006年欧洲肾脏协会 - 欧洲透析与移植协会（ERA - EDTA）登记报告的总结。
关于肾脏替代治疗（RRT）的数据来自欧洲28个国家以及地中海周边国家的50个国家和地区登记处。从35个登记处收到了包含个体患者数据的数据集，而17个登记处以汇总形式提供数据。对于这两种类型的登记处，我们都给出了发病率、患病率和移植率。生存分析以及预期剩余寿命的计算仅基于个体患者记录。
2006年，在向ERA - EDTA登记处报告的所有登记处中，RRT的总体年发病率为每百万人口118例（pmp），患病率为630 pmp。发病率从德国的213 pmp到乌克兰的18 pmp不等。终末期肾病（ESRD）的RRT总体发病率自2004年开始下降。西班牙坎塔布里亚报告的ESRD的RRT患病率最高（1,234 pmp），乌克兰最低（73 pmp）。总体移植率在西班牙最高（61 pmp），而活体供肾移植率最高的是冰岛（26 pmp）。1997 - 2001年队列中接受RRT患者未经调整的1年、2年和5年生存率分别为82.3（95%置信区间[95%CI]，82.0 - 82.5）、70.9（95%CI，70.7 - 71.2）和47.5（95%CI，47.3 - 47.6）。
